{"filing":{"accession_number":"0001493152-26-033191","cik":"0001326706","ticker":"FEED","company_name":"ENvue Medical, Inc.","form":"8-K","filing_date":"2026-07-14","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315226033191/form8-k.htm"},"events":[{"id":17910,"run_id":16069,"accession_number":"0001493152-26-033191","anchor_item_number":null,"event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.75,"summary":"The filing discloses multiple governance events on July 14, 2026: the voluntary resignations of two board members (David Johnson and Nino Pionati), the appointment of two new directors (Zvi Joseph and Lior Buchman) to fill those vacancies, and the appointment of Zeev Rotstein, M.D. as the new Board Chairman. While both departures and appointments occur, the filing treats them as a coordinated board transition rather than emphasizing either departure or appointment alone. The changes affect board composition and committee assignments, making this a material governance restructuring that would affect investor assessment of the company's leadership.","company_name":"ENvue Medical, Inc.","ticker":"FEED","filing_date":"2026-07-14","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":16557,"accession_number":"0001493152-26-033191","item_number":null,"item_title":null,"event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"The filing discloses multiple governance events on July 14, 2026: the voluntary resignations of two board members (David Johnson and Nino Pionati), the appointment of two new directors (Zvi Joseph and Lior Buchman) to fill those vacancies, and the appointment of Zeev Rotstein, M.D. as the new Board Chairman. While both departures and appointments occur, the filing treats them as a coordinated board transition rather than emphasizing either departure or appointment alone. The changes affect board composition and committee assignments, making this a material governance restructuring that would affect investor assessment of the company's leadership.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-14T20:51:56.127865+00:00","company_name":"ENvue Medical, Inc.","ticker":"FEED","filing_date":"2026-07-14"}]}